Product logins

Find logins to all Clarivate products below.


Interventional Oncology Devices | Market Insights | Japan | 2024

The Japanese interventional oncology device market will grow slowly due to limited adoption of minimally invasive interventional oncology procedures, substantiated by Japanese guidelines and increasing developments in anticancer drugs, limiting the growth.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for interventional oncology devices in Japan from 2019 to 2032.

Related Medtech Insights Reports

Report
Diagnostic Imaging Systems – Market Insights – Japan
Japan’s diagnostic imaging system market will experience slow growth through 2034, driven by continuous technological advancement and rising hospital demand for efficient, patient-centric imaging…
Report
Laparoscopic Devices – Market Insights – Japan
The Japanese laparoscopic device market will expand modestly through 2034, driven by rising demand for MIS procedures among the country’s rapidly aging population. Additionally, the adoption of…
Report
Urological Devices – Market Insights – Japan
The Japanese urological device market will continue to expand through 2034, driven by the rising prevalence of risk factors for urological disorders, such as the growing burden of metabolic…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Japan
The Japanese EP mapping and ablation device market will experience moderate growth through 2034, supported by rising cardiac arrhythmia prevalence, broader treatment accessibility, and ongoing…
Report
Interventional Oncology Devices – Market Insights – United States
The US market for interventional oncology devices will be driven by the launch and uptake of higher-priced technologies, favorable clinical data, expanding populations that are treatable with…